Clément H.
- Country
- France
- Department
- intensive care
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Critical Care & Organ Support
The investigator concentrates on life‑support strategies for patients admitted to intensive care, emphasizing hemodynamic stabilization, mechanical ventilation, and extracorporeal therapies.
- septic shock
- veno‑arterial ECMO
- invasive mechanical ventilation
- post‑resuscitation syndrome
- acute kidney injury
These efforts aim to improve survival and organ recovery in the most critically ill populations.
Cardiovascular & Cerebrovascular Emergencies
Focused on acute cardiac and cerebrovascular events, the investigator evaluates therapeutic interventions that limit tissue damage and prevent recurrent events.
- acute myocardial infarction
- acute coronary syndrome
- ischemic stroke
- high‑risk transient ischemic attack
- cardiogenic shock
Research targets rapid reperfusion, hemodynamic optimization, and secondary prevention.
Hematologic Malignancies & Stem Cell Transplantation
In the realm of onco‑hematology, the investigator investigates novel approaches for aggressive leukemias, lymphomas, and post‑transplant complications.
- acute myeloid leukemia
- acute lymphoblastic leukemia
- allogeneic hematopoietic stem cell transplantation
- graft‑versus‑host disease
- relapsed/refractory lymphoma
Therapeutic goals include disease eradication, transplant tolerance, and reduction of mortality.
Pulmonary & Respiratory Failure
The investigator’s work addresses severe pulmonary disorders that often require intensive management, including ventilation strategies and targeted pharmacotherapy.
- acute respiratory distress syndrome
- interstitial lung disease
- pulmonary arterial hypertension
- chronic obstructive pulmonary disease
- ventilator‑associated pneumonia
These initiatives seek to improve gas exchange, reduce ventilator dependence, and limit infection risk.
Metabolic, Renal & Endocrine Syndromes
Research extends to metabolic derangements and renal pathologies often encountered in intensive settings, with attention to cardiovascular risk modulation.
- non‑alcoholic steatohepatitis
- type 2 diabetes mellitus
- chronic kidney disease
- hypertension
- metabolic dysfunction‑associated steatotic liver disease
Efforts focus on disease progression attenuation and integration of organ‑protective strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.